Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

In 2005, we performed the largest survey on clinical trials of biotherapies for all solid tumors and found indirect evidence of a publication bias: editors of medical journals were more prone to publish positive results independently from the quality of the studies. We collected data from 2003 to 20...

Full description

Bibliographic Details
Main Authors: Alessandro Ottaiano, Antonino Cassata, Monica Capozzi, Chiara De Divitiis, Alfonso De Stefano, Antonio Avallone
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Oncology
Subjects:
biotherapies
publication bias
solid tumors
survey
methodology
Online Access:http://journal.frontiersin.org/article/10.3389/fonc.2018.00062/full

Internet

http://journal.frontiersin.org/article/10.3389/fonc.2018.00062/full

Similar Items